T
hyroid hormone regulates many developmental processes that vary in their tissue specificity and the stage at which they occur. An important question therefore concerns the means by which this systemic hormonal signal is able to elicit its specific actions in a given tissue at the appropriate time. Hearing is one of the most sensitive functions controlled by thyroid hormone, and early-onset hypothyroidism or iodine deficiency are known causes of deafness in humans and rodent model species (1) (2) (3) (4) (5) . Thyroid hormone is required for the timely coordination of a complex set of differentiation events in the maturing cochlea. In rodents, the cochlea is largely formed by birth, and it then proceeds through a period of differentiation during which auditory function initiates around postnatal day 13 (P13) and matures by ϷP20 (6, 7) . Hypothyroidism during this period retards the differentiation of the cochlea, including the epithelium that contains the sensory hair cells (1, 3, 8, 9) . The mechanisms that prompt the progression of these developmental events are poorly understood.
Thyroid hormone receptors TR␤ and TR␣1 are ligandregulated transcription factors and are expressed in the sensory epithelium and other tissues in the rodent cochlea from midgestation into the postnatal period (10, 11) . TR␤-deficient mice display auditory deficits with a subset of hypothyroid-like abnormalities in the cochlea (12, 13) . TR␣1 is individually dispensable for hearing, whereas deletion of both TR␤ and TR␣1 produces exacerbated defects that resemble those caused by hypothyroidism (13) (14) (15) . Some human TR␤ mutations are associated with hearing loss (16) (17) (18) . Although TRs are necessary mediators of thyroid hormone signaling, it is unclear which other factors influence TR activity during cochlear development.
Thyroid hormone may be metabolically activated or inactivated by iodothyronine deiodinases (19) (20) (21) . Thyroxine (T4), the main product released by the thyroid gland into the circulation is converted by outer ring 5Ј-deiodination into 3,5,3Ј-triiodothyronine (T3) the principal ligand of the TR. This conversion is mediated by deiodinase type 2 (D2) and deiodinase type 1 (D1) encoded by Dio2 and Dio1, respectively. Deiodinase type 3 (D3) depletes tissues of active hormone by inner ring deiodination of T4 and T3. The differential expression of D1, D2, and D3 in some tissues (22) (23) (24) (25) (26) raises the possibility that deiodinases play specific developmental roles. Previously, we identified prominent expression of D2 in the early postnatal mouse cochlea, suggesting a role for D2 in the development of hearing (27) . D2 is expressed in the cochlear capsule and connective tissues that surround the internal sensory tissues. Here, we report an essential role for D2 in the development of the auditory system.
Methods
Mouse Strains. The targeted deletion of Dio2 was carried on a mixed background of 129͞SvJ ϫ C57BL͞6 strains, as described (28) . The mutation was backcrossed for two further generations onto the C57BL͞6J strain (The Jackson Laboratory, no. 000664) that has minimal hearing loss before 6 months of age (13, 29) . Genotyping was performed on genomic DNA by PCR with primers specific for neo in the Dio2 Ϫ mutant allele and for a region of intron 1 and exon 2 specific for the WT gene (GenBank accession no. NT039552). Primer sequences were: neo sense and antisense, GTGTTCCGGCTGTCAGCGC and GTCCTGAT-AGCGGTCCGCCA, respectively; and Dio2 sense and antisense, GACCATCCTTTATATTGCCTGACATG and GGCG-GAAGGCTGGCAGTTGCC, respectively. Dio2 Ϫ/Ϫ and control littermates were derived from crosses of Dio2 ϩ/Ϫ parents or Dio2 Ϫ/Ϫ male and Dio2 ϩ/Ϫ females. Nursing dams or pregnant dams at 14.5-17.5 days postcoitum were treated with 0.3 or 1.0 g͞ml L-triiodothyronine (Sigma) in drinking water. Animal studies were conducted under approved protocols at Mount Sinai School of Medicine and Dartmouth Medical School. Statistical analyses were performed by using the Student t test. stimulus level that gave a recognizable waveform on a normalized scale. For presentation in figures, a fixed scale is used.
Histology, Immunohistochemistry, and Electron Microscopy. Cochleae were fixed in 3% glutaraldehyde͞2% paraformaldehyde, decalcified, embedded in methacrylate, sectioned at 3-5 m, and stained with thionin, as described (13) . Groups of four to six cochleae from three mice were analyzed. Cryosections made from paraformaldehyde-fixed tissues were immunostained with antibodies against ␣-and ␤-tectorins by using detection with FITC-conjugated secondary antibodies (30) . Tectorial membrane (TM) ultrastructure was examined in ultrathin sections by transmission electron microscopy, as described (13) I]T3 (specific activities Ϸ1,000 Ci͞g) were obtained from Perkin-Elmer and purified by chromatography using Sephadex LH-20 (Sigma) before use. Total T4 and total T3 levels were determined by RIA using Coat-A-Count reagents (Diagnostic Systems Laboratories, Webster, TX) (28) or a chemiluminescent assay for T4 on an Advia Centaur instrument (Bayer HealthCare, Tarrytown, NY) and a fluorometric assay for T3 on an Abbott AxSYM instrument. Coefficients of variation were 6-10% for T4 and 5-13% for T3.
Northern Blot Analysis. Total RNA samples from pools of cochleae from P8 pups (Ϸ30 per genotype) were analyzed with a glyceraldehyde-3-phosphate dehydrogenase probe and a 1.4-kb mouse D2 cDNA probe (B1), extending from the fifth codon to 561 bp downstream of the stop codon in the 3Ј untranslated sequence, as described (27) .
Results

Auditory Deficits in Dio2
mice are a suitable model for the analysis of auditory function as they lack gross developmental defects (28, 31) . The deletion in the major coding exon of Dio2 (28) allowed mice to be genotyped by PCR, as shown in Fig. 1A . Northern blot analysis detected a 7.0-kb D2 mRNA in cochlear samples from WT and Dio2 ϩ/Ϫ pups but not from Dio2 Ϫ/Ϫ pups (Fig. 1B) . Normally, cochlear D2 activity rises during the first postnatal week and is abundant at P8 (27) . Cochlear homogenates from Dio2 Ϫ/Ϫ pups at P8 lacked 5Ј-deiodinase activity, assayed with T4 or reverse T3 substrates ( Thus, no compensatory changes in D1 or D3 were evident in the cochlea in Dio2 Ϫ/Ϫ mice.
To rule out systemic hypothyroidism in development as a cause of any deafness, thyroid hormone levels were determined in serum of WT and Dio2 Ϫ/Ϫ mice between P8 and P25 (Fig. 1D) . Dio2 Ϫ/Ϫ pups displayed moderately elevated T3 and T4 levels, whereas Dio2 Ϫ/Ϫ adults, as reported previously, had slight T4 increases caused by a mild dysfunction of the pituitary-thyroid axis (28) . The degree of elevation of T4 and T3 was greater in younger Dio2 Ϫ/Ϫ pups but moderated by P16. Thus, no general deficiency of thyroid hormones occurred in Dio2
Hypothyroidism presents a known risk to hearing but a modest thyroid hormone increase would not cause overt deafness (12, 32) (and see Fig. 5 ). from P8 pups detected a major 7-kb D2 band only in Dio2 ϩ/ϩ and Dio2 ϩ/Ϫ mice. A glyceraldehyde 3-phosphate dehydrogenase (G3PDH) control probe was used on the same blot. (C) D2 5Ј-deiodinase activity in cochlear homogenates from P8 mice assayed with T4 or reverse T3 substrates. Activity was undetectable in Dio2 Ϫ/Ϫ samples, and in Dio2 ϩ/Ϫ mice it was Ϸ50% below WT levels ( * , P Ͻ0.05). Results were similar in the presence or absence of propylthiouracil (PTU), an inhibitor of D1. D3 activity was detected at similar, low levels in all genotypes. (D) Serum levels of total T4 and total T3 during development in Dio2 Ϫ/Ϫ and WT mice. In Dio2 Ϫ/Ϫ mice, T4 was somewhat elevated and T3 was normal or slightly elevated.
To assess hearing, the ABR was measured in WT, Dio2 Ϫ/Ϫ mice and could be evoked only with a significantly increased SPL ( Fig. 2A) . In 1-month-old Dio2 Ϫ/Ϫ mice, the mean threshold for a click stimulus was 79 Ϯ 2 dB SPL, an increase of 40 dB above normal (WT, 39 Ϯ 2 dB SPL; P Ͻ0.001), indicating a severe, although not total, impairment of auditory function. ABR waveforms in mice typically display four to five peaks with the first two to three peaks representing responses from the cochlea and proximal brainstem centers (29, 33) . In Dio2
mice, all peaks were poorly defined and had prolonged latency (Fig. 2B) . Using a click stimulus at 90 dB SPL, mean latencies to peak IV in WT, Dio2 mice revealed retarded differentiation of the cochlear inner sulcus and sensory epithelium and deformity of the TM, a secreted extracellular matrix that is necessary for the response of the mechanosensitive hair cells to sound stimulation (30) . The defects detected in Dio2 Ϫ/Ϫ mice resided in known thyroid hormone-sensitive tissues in the cochlear interior rather than in the surrounding connective tissues that normally express D2 (i.e., the cochlear capsule, the septal divisions between the turns of the cochlea, and the modiolus) (27) .
Normally at P8, the sensory epithelium forms three distinct rows of outer hair cells and one row of inner hair cells separated by the tunnel of Corti, whereas the inner sulcus epithelium is partly retracted below the TM (Fig. 3A) . In the adult, the TM extends fully across the cavity of the inner sulcus to contact the stereociliary bundles of the hair cells (Fig. 3D) . In Dio2 Ϫ/Ϫ pups at P8, the sensory epithelium was poorly differentiated, the tunnel of Corti was unopened, and the inner sulcus was only at an early stage of formation (Fig. 3B) . The inner sulcus epithelium was thicker with taller columnar cells than in WT pups. The TM was enlarged and attached for most of its length to the underlying epithelium. Occasionally, the TM was thinner and the inner sulcus was partly developed, suggesting variable penetrance for part of the phenotype (Fig. 3C) . However, all Dio2 Ϫ/Ϫ pups showed retarded differentiation of the sensory epithelium. The TM enlargement was evident as early as P4 but other morphological changes were not observed before P4 in Dio2
In adult Dio2
mice, the differentiation of many features of the sensory epithelium and the opening of the tunnel of Corti had progressed to resemble the WT cochlea. The TM, however, remained variably malformed (Fig. 3E) . The TM deformity was (B) Representative ABR waveforms for a click stimulus, shown on a 4-V fixed scale. Thresholds are underlined. Normally, four main peaks (marked I-IV) were detected within 5 ms of stimulation (a fifth peak is often not discernible in mice). In Dio2 Ϫ/Ϫ mice, waveforms were poorly defined with reduced amplitude and prolonged latency (assignment of specific peak numbers was precluded in some Dio2 Ϫ/Ϫ mice because of this poor definition). usually slight in adults although Fig. 3F shows an extreme example with a severely malformed TM and disorganization of the sensory epithelium, indicating degeneration or aborted development of these tissues.
The ultrastructure of the TM in Dio2 Ϫ/Ϫ mice was also abnormal. The normal TM contains a series of major collagen fibrils embedded in a striated sheet matrix of fine filaments (Fig.  4A) (34) . In Dio2 Ϫ/Ϫ mice, the major fibrils were present but the striated sheet matrix was disorganized in the middle and upper regions of the TM (Fig. 4B) . The matrix, however, was normal in lower regions of the TM lying closest to the inner sulcus. The TM still contained the major ␣-and ␤-tectorin glycoproteins as found in WT mice (Fig. 4C) (30) . This finding suggests, that as in TR-deficient mice, the lack of D2 does not block expression of TM components but instead may impair their assembly or processing. The cochlear defects in Dio2 Ϫ/Ϫ mice and the TM deformity with a partial disorganization of ultrastructure closely resembled the phenotype in TR␤-deficient mice. The TM abnormalities, however, were milder than in mice lacking both TR␤ and TR␣1, in which ultrastructural disorganization occurred throughout all regions of the TM (13).
Recovery of Auditory Sensitivity by T3 Administration. The auditory phenotype in Dio2 Ϫ/Ϫ mice was remarkably similar to that caused by hypothyroidism despite the fact that Dio2 Ϫ/Ϫ mice possess serum levels of T4 and T3 that would normally be adequate for the development of hearing. This finding suggests that D2 is required to generate T3 in the auditory system above levels available in serum in postnatal development. Therefore, we tested whether T3 supplementation could overcome such a local T3 insufficiency in Dio2 Ϫ/Ϫ mice. T3 was added at different starting points to the drinking water of nursing Dio2 ϩ/Ϫ dams or weaned progeny until P28 when the ABR was measured. Treatment from P10 with 0.3 g͞ml T3 resulted in 2-to 5-fold increases in serum T3 when measured at P16 (Fig. 5B) . After weaning at P21, mice that ingested T3 directly had 8-to 12-fold increased serum T3 levels (n ϭ 8).
T3 given from P10 improved the mean ABR thresholds by Ϸ30 dB SPL in Dio2 Ϫ/Ϫ mice compared to untreated Dio2 Ϫ/Ϫ mice (Fig. 5A) . The improvement was nearly complete in most Dio2 Ϫ/Ϫ mice although 30% showed only a limited recovery. A lesser degree of correction was achieved when T3 was given later. Treatment of Dio2 Ϫ/Ϫ pups from P16 improved ABR thresholds by Ϸ10 dB SPL, whereas treatment from P23 did not correct thresholds. T3 treatment of Dio2 Ϫ/Ϫ mice also enhanced the definition of the waveform (Fig. 5C and see untreated example in Fig. 2B ) and improved its latency (with T3 treatment from P10, peak IV latency was shortened from 5.75 Ϯ 0.19 to 4.87 Ϯ 0.31 ms; n ϭ 8; P Ͻ0.01). Thresholds were in the normal range in Dio2 ϩ/Ϫ or WT controls regardless of treatment.
Higher T3 doses produced systemic toxicity but paradoxically still improved ABR thresholds. T3 treatment (1 g͞ml) begun in utero retarded body growth of Dio2 Ϫ/Ϫ pups, which attained Ϸ60% of untreated weight at weaning (at P22, Dio2 Ϫ/Ϫ female treated, 5.8 Ϯ 1.2, untreated 9.6 Ϯ 0.4 g; male treated, 4.9 Ϯ 1.0, untreated 9.2 Ϯ 0.7 g; n ϭ 4-6; P Ͻ0.001). Mice in these treated groups showed Ն30 dB SPL improvements in ABR thresholds compared to untreated Dio2 Ϫ/Ϫ mice (n ϭ 14; P Ͻ0.001), although 30% (4 of 14) had only slight improvement. Treatment of Dio2 ϩ/Ϫ control mice from embryonic stages, but not from P10 or later, also resulted in some progeny (3 of 12) acquiring a defective ABR. These findings suggest that the embryonic or neonatal auditory system is susceptible to impairment by excessive T3 regardless of genotype. The improvement of auditory sensitivity by T3 administration identified a T3 deficiency as the critical defect underlying the deafness in Dio2 Ϫ/Ϫ mice, in accord with the activity of D2 in generating T3.
T3 treatment also improved cochlear differentiation in Dio2 Ϫ/Ϫ mice. In untreated Dio2 Ϫ/Ϫ mice at P16 (Fig. 5D) , differentiation had progressed from the immature state shown at P8 in Fig. 3B to form distinct hair cells and an open tunnel of Corti. However, the inner sulcus epithelium adjacent to the inner hair cells was thicker with a denser array of columnar cells than in Dio2 ϩ/Ϫ pups and the TM remained malformed. In Dio2 Ϫ/Ϫ pups treated with T3 from P10 until analysis at P16, morphology more closely resembled the normal state for that stage of development with a better differentiated inner sulcus epithelium and thinner TM (Fig. 5E ). T3 treatment did not produce obvious abnormalities in Dio2 ϩ/Ϫ control pups (Fig. 5 F and G) .
Discussion
This study reveals that D2 is essential for the development of hearing. The similarity of the cochlear phenotypes caused by D2 or TR deficiency suggests that D2 controls the T3 signal in the cochlea to activate the TR at a critical phase of development. On a comparative scale, the auditory phenotype in Dio2 Ϫ/Ϫ mice is slightly worse than in TR␤-deficient mice but is milder than that caused by deletion of both TR␤ and TR␣1 (13) or by severe systemic hypothyroidism (1) . The differences in severity may be explained if the normal to slightly increased levels of circulating T3 in Dio2 Ϫ/Ϫ pups provide small amounts of ligand that stimulate limited activity by TR␤ and TR␣1 in the cochlea. In contrast, systemic hypothyroidism or the deletion of all TRs would cause a more absolute block of thyroid hormone signaling. The variable severity of some features of the Dio2 Ϫ/Ϫ phenotype is consistent with the enzymic role of D2 in generating subtle T3 fluxes in the cochlea, which may be expected to vary somewhat among individuals.
Why is the development of the auditory system so dependent on D2 and why would the maturing cochlea in effect stimulate its own response to thyroid hormone? The finding that normal or marginally increased serum levels of T3 are inadequate for the demands of the cochlea supports the role of D2 as a tissuespecific amplifier of T3 action. Thus, D2 would draw on the T4 supply in serum and convert this into T3 at the necessary stage of development. The demands for T3 in the postnatal cochlea may be considerable given the range of differentiation events that require thyroid hormone in the inner sulcus, sensory epithelium, spiral ganglion, and auditory nerve and in the formation of the TM (1, 3, 11, 13, 15) . D2 may have other functions in central auditory pathways because D2 mRNA is also expressed widely in the brain, including in central auditory regions (24) . Indeed, the poor overall definition and prolonged latency of the ABR waveform in Dio2 Ϫ/Ϫ mice raises the possibility that defects exist not only in the cochlea but also in the auditory nerve and brainstem auditory regions. Further study is necessary to determine whether there is any type of brain defect in Dio2 Ϫ/Ϫ mice. The improvement of auditory sensitivity by high T3 doses that otherwise retard body growth in Dio2 Ϫ/Ϫ pups emphasizes the differential demands of the auditory and other systems for T3 at certain developmental stages. Thus, the local amplification of the hormonal signal by D2 would provide an efficient means of coordinating multiple developmental events in the maturing auditory system. Moreover, the location of D2 in the auditory system itself may confer immediacy in prompting the timely maturation of this sensory system.
The results suggest that T3 signaling regulates not only the onset of auditory function but also the subsequent maturation of auditory sensitivity. The maturation of auditory function in rodents occurs over a protracted period lasting until ϷP20 (6, 7). A continuing role for D2 over this period would explain why T3 administration begun as late as P16 partly improves auditory sensitivity in Dio2 Ϫ/Ϫ mice. Possibly, some functions are simply arrested and the later provision of T3 is able to reactivate these differentiation events. The chambered structure of the cochlea points to the likelihood that D2 function is integrated with currently unknown mechanisms that would transport specific forms of thyroid hormones across the compartments of the cochlear microenvironment. A paracrine-like action of thyroid hormone may therefore operate involving T4 uptake, the generation of T3 by D2, and the release of this T3 to stimulate responsive tissues in the cochlear interior.
D3, a thyroid hormone-inactivating enzyme, has been shown to regulate Xenopus eye development, probably by reducing local levels of thyroid hormone in the dorsal retina (25) . Our results suggest that the hormone-activating D2 enzyme provides an equally potent developmental control but through an opposite mechanism of amplifying T3 action. Thus, both enzymes may promote critical tissue-specific variations in local T3 levels in development. Somewhat analogously, the enzymes that synthesize and degrade retinoic acid are thought to control the activity of retinoid receptors (35) . The findings in Dio2 Ϫ/Ϫ mice suggest T3 recovers auditory sensitivity in Dio2 Ϫ/Ϫ mice. (A) Mean ABR thresholds ϮSEM in mice at P28 after T3 treatment starting at P10, P16, or P23. Untreated groups are shown in columns marked Ϫ. T3 was given in drinking water (0.3 g͞ml) to nursing dams and weaned progeny. Compared to untreated mice, thresholds were substantially corrected in Dio2 Ϫ/Ϫ progeny when treatment started at P10 (P ϭ 0.002), partly corrected when started at P16 (P ϭ 0.005), and not significantly corrected when started at P23 (P ϭ 0.06). Similar results were obtained for 8-, 16-, and 32-kHz stimuli. (B) Serum levels of total T3 and total T4 in P16 pups after T3 treatment (0.3 g͞ml) from P10. Treatment (ϩT3) increased T3 levels 2-to 5-fold over untreated levels (ϪT3). As expected, T3 treatment also suppressed the function of the pituitarythyroid axis, thereby reducing T4 levels. Groups contained two pools of serum from 16 -20 pups except for the T4 assays in ϩT3 groups, which contained single pools of serum from n ϭ 5-8 pups. (C) The thresholds and definition of ABR waveforms were improved in Dio2 Ϫ/Ϫ mice when treated from P10, but were less improved when treated from P16 and not improved when treated from P23. Thresholds are underlined. Traces are shown on a 4-V fixed scale. (D-G) Improved cochlear morphology in Dio2 Ϫ/Ϫ mice after T3 treatment from P10 until analysis at P16. In untreated Dio2 Ϫ/Ϫ pups (D), the TM is malformed and the inner sulcus epithelium (ISE) is thicker with taller, columnar cells than in untreated Dio2 ϩ/Ϫ pups (F). T3 improved ISE differentiation and the shape of the TM in Dio2 Ϫ/Ϫ pups (E) but did not obviously alter morphology in that the amplification of thyroid hormone action in the target organ itself provides an important developmental control in the auditory system.
